Amanda Tchakarov

623 total citations
34 papers, 405 citations indexed

About

Amanda Tchakarov is a scholar working on Oncology, Nephrology and Genetics. According to data from OpenAlex, Amanda Tchakarov has authored 34 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Nephrology and 6 papers in Genetics. Recurrent topics in Amanda Tchakarov's work include Cancer Immunotherapy and Biomarkers (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal cell carcinoma treatment (3 papers). Amanda Tchakarov is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal cell carcinoma treatment (3 papers). Amanda Tchakarov collaborates with scholars based in United States, Egypt and Italy. Amanda Tchakarov's co-authors include Jamie S. Lin, Ala Abudayyeh, Omar Mamlouk, William F. Glass, Noha Abdel‐Wahab, Cassian Yee, Maen Abdelrahim, Umut Selamet, Adi Diab and Nizar M. Tannir and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Society of Nephrology.

In The Last Decade

Amanda Tchakarov

28 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Tchakarov United States 8 260 137 90 75 40 34 405
Omar Mamlouk United States 9 344 1.3× 158 1.2× 106 1.2× 69 0.9× 70 1.8× 33 476
J-L. Canon Belgium 9 264 1.0× 119 0.9× 47 0.5× 31 0.4× 41 1.0× 29 406
S K Mak China 7 60 0.2× 106 0.8× 219 2.4× 62 0.8× 60 1.5× 12 385
Hiroyuki Watanabe Japan 13 217 0.8× 93 0.7× 18 0.2× 42 0.6× 27 0.7× 37 414
Yuyan Zheng China 11 136 0.5× 202 1.5× 95 1.1× 24 0.3× 26 0.7× 29 435
L Rivabella Italy 7 58 0.2× 81 0.6× 133 1.5× 114 1.5× 37 0.9× 14 397
Y Kadotani Japan 10 47 0.2× 114 0.8× 63 0.7× 31 0.4× 27 0.7× 35 345
Luisa Ricaurte United States 11 97 0.4× 171 1.2× 67 0.7× 15 0.2× 31 0.8× 25 370
Paul Zorsky United States 10 208 0.8× 56 0.4× 21 0.2× 37 0.5× 46 1.1× 16 399
Kichul Ko United States 12 75 0.3× 59 0.4× 158 1.8× 253 3.4× 26 0.7× 20 498

Countries citing papers authored by Amanda Tchakarov

Since Specialization
Citations

This map shows the geographic impact of Amanda Tchakarov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Tchakarov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Tchakarov more than expected).

Fields of papers citing papers by Amanda Tchakarov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Tchakarov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Tchakarov. The network helps show where Amanda Tchakarov may publish in the future.

Co-authorship network of co-authors of Amanda Tchakarov

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Tchakarov. A scholar is included among the top collaborators of Amanda Tchakarov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Tchakarov. Amanda Tchakarov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amer, Radgonde, et al.. (2024). Recurrent Lupus Nephritis in a Kidney Transplant Patient. Journal of the American Society of Nephrology. 35(10S).
2.
Tchakarov, Amanda, et al.. (2024). Diffuse alveolar haemorrhage due to atypical hemolytic uremic syndrome (aHUS) associated with COVID‐19. SHILAP Revista de lepidopterología. 12(4). e01350–e01350. 1 indexed citations
3.
Tchakarov, Amanda, et al.. (2024). Double Jeopardy: Monoclonal Gammopathy of Renal Significance (MGRS) in the Shadow of Lupus Nephritis. Journal of the American Society of Nephrology. 35(10S).
4.
Tchakarov, Amanda, et al.. (2024). Rituximab in Treatment of Glomerulonephritis Induced after Immune Checkpoint Inhibitors. Journal of the American Society of Nephrology. 35(10S). 1 indexed citations
5.
Davis, Jessica L., Ivy John, Rita Alaggio, et al.. (2023). ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase–Altered Mesenchymal Tumors. Modern Pathology. 36(12). 100334–100334. 12 indexed citations
6.
Tchakarov, Amanda, Maen Abdelrahim, María E. Suarez‐Almazor, et al.. (2023). Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab. SHILAP Revista de lepidopterología. 3. 1168614–1168614. 2 indexed citations
7.
Tchakarov, Amanda, et al.. (2022). The Use of Rituximab in Treatment of Immune Checkpoint Inhibitor Induced Glomerulonephritis. Journal of the American Society of Nephrology. 33(11S). 374–374.
8.
Tchakarov, Amanda, et al.. (2022). BK Nephropathy in Hematopoietic Stem Cell Transplant Patients: An Upcoming Challenge. Journal of the American Society of Nephrology. 33(11S). 844–844.
9.
Tchakarov, Amanda, et al.. (2022). Immune Checkpoint Inhibitor Induced Multi Organ Sarcoid-Like Reaction. Journal of the American Society of Nephrology. 33(11S). 380–380.
10.
11.
Singh, Shailbala, James P. Long, Amanda Tchakarov, et al.. (2022). Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis. JCI Insight. 25 indexed citations
12.
Abudayyeh, Ala, et al.. (2022). Onconephrology and Thrombotic Microangiopathy: Looking Beyond the Horizon. Seminars in Nephrology. 42(6). 151345–151345. 5 indexed citations
13.
Hamad, Christopher D., et al.. (2022). Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma. CEN Case Reports. 11(3). 321–327. 3 indexed citations
14.
Weng, Julius, Jaffer A. Ajani, M Murphy, et al.. (2022). Immunotherapy Recall: Chemoradiation-Induced Reactivation of Immune Checkpoint Inhibitor Nephritis. JCO Precision Oncology. 6(6). e2200049–e2200049. 1 indexed citations
15.
Mamlouk, Omar, et al.. (2021). Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor. Kidney Medicine. 3(2). 294–298. 5 indexed citations
16.
Mamlouk, Omar, Jamie S. Lin, Maen Abdelrahim, et al.. (2020). Checkpoint Inhibitor-Related Renal Vasculitis and Use of Rituximab. Journal of the American Society of Nephrology. 31(10S). 662–662. 2 indexed citations
17.
Mamlouk, Omar, Jamie S. Lin, Maen Abdelrahim, et al.. (2020). Checkpoint inhibitor-related renal vasculitis and use of rituximab. Journal for ImmunoTherapy of Cancer. 8(2). e000750–e000750. 33 indexed citations
18.
Mamlouk, Omar, Umut Selamet, Maen Abdelrahim, et al.. (2019). Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. Journal for ImmunoTherapy of Cancer. 7(1). 2–2. 199 indexed citations
19.
20.
Tchakarov, Amanda, Maen Abdelrahim, Victor E. Mulanovich, et al.. (2016). Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury. Bone Marrow Transplantation. 51(10). 1301–1304. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omar Mamlouk Breakdown of academic impact, for papers by J-L. Canon Breakdown of academic impact, for papers by S K Mak Breakdown of academic impact, for papers by Hiroyuki Watanabe Breakdown of academic impact, for papers by Yuyan Zheng Breakdown of academic impact, for papers by L Rivabella Breakdown of academic impact, for papers by Y Kadotani Breakdown of academic impact, for papers by Luisa Ricaurte Breakdown of academic impact, for papers by Paul Zorsky Breakdown of academic impact, for papers by Kichul Ko
Rankless by CCL
2026